A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
- Massachusetts General Hospital, Boston, MA (United States). Mongan Inst. Clinical and Translational Epidemiology Unit; Harvard Medical School, Boston, MA (United States). Dept. of Medicine; Broad Inst. of MIT and Harvard, Cambridge, MA (United States). Programs in Metabolism and Medical & Population Genetics
- Wayne State Univ., Detroit, MI (United States). Center for Molecular Medicine & Genetics
- Wayne State Univ., Detroit, MI (United States). Center for Molecular Medicine & Genetics
- Wayne State Univ., Detroit, MI (United States). Center for Molecular Medicine & Genetics; Wayne State Univ., Detroit, MI (United States). Karmanos Cancer Inst.
- Broad Inst. of MIT and Harvard, Cambridge, MA (United States). Programs in Metabolism and Medical & Population Genetics; Massachusetts General Hospital, Boston, MA (United States). Center for Genomic Medicine; Massachusetts General Hospital, Boston, MA (United States). Division of General Internal Medicine
- Massachusetts General Hospital, Boston, MA (United States). Center for Genomic Medicine; Massachusetts General Hospital, Boston, MA (United States). Diabetes Unit
- Univ. of California, Berkeley, CA (United States). Dept. of Statistics; Univ. of Birmingham (United Kingdom). Centre for Computational Biology; Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Biosciences Area. Computational Biosciences Group
- Cedars-Sinai Medical Center, Los Angeles, CA (United States). Dept. of Medicine. Division of Endocrinology, Diabetes, and Metabolism
- The Lundquist Inst. for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (United States). Dept. of Pediatrics. The Inst. for Translational Genomics and Population Sciences
- McGill Univ., Montreal, QC (Canada). Dept. of Human Genetics; McGill Univ., Montreal, QC (Canada). Dept. of medicine; McGill Univ. and Genome Québec Innovation Centre, Montréal, QC (Canada)
- Harvard Medical School, Boston, MA (United States). Dept. of Medicine; Broad Inst. of MIT and Harvard, Cambridge, MA (United States). Programs in Metabolism and Medical & Population Genetics; Massachusetts General Hospital, Boston, MA (United States). Division of General Internal Medicine
- Wayne State Univ., Detroit, MI (United States). Center for Molecular Medicine & Genetics; Wayne State Univ., Detroit, MI (United States). School of Medicine. Dept. of Neurology
Causal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3B, which encodes a key protein regulating insulin-mediated hepatic glycogen storage in humans. We hypothesized that LOC157273 regulates expression of PPP1R3B in human hepatocytes. We tested our hypothesis using Stellaris fluorescent in situ hybridization to assess subcellular localization of LOC157273; small interfering RNA (siRNA) knockdown of LOC157273, followed by RT-PCR to quantify LOC157273 and PPP1R3B expression; RNA-seq to quantify the whole-transcriptome gene expression response to LOC157273 knockdown; and an insulin-stimulated assay to measure hepatocyte glycogen deposition before and after knockdown. We found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. An A/G heterozygous carrier (vs. three G/G carriers) had reduced LOC157273 abundance due to reduced transcription of the A allele and increased PPP1R3B expression and glycogen deposition. We show that the lncRNA LOC157273 is a negative regulator of PPP1R3B expression and glycogen deposition in human hepatocytes and a causal transcript at an insulin-resistant T2D risk locus.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1816102
- Journal Information:
- Frontiers in Genetics, Vol. 11; ISSN 1664-8021
- Publisher:
- Frontiers Media S.A.Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Targeting long non-coding RNA ASBEL with oligonucleotide antagonist for breast cancer therapy
LncRNA MALAT1 is up-regulated in diabetic gastroparesis and involved in high-glucose-induced cellular processes in human gastric smooth muscle cells